Neuralink, Elon Musk’s brain-computer venture, and rivals like Max Hodak’s Science, are chasing advances in technology that ...

Compounding pharmacies are typically allowed to make copies of drugs that are deemed to be in shortage by the FDA, which semaglutide has been for over two years. But Novo argued that semaglutide ...

In September, Neuralink received a "breakthrough device" designation from the Food and Drug Administration for its "Blindsight" brain implant, which Elon Musk claims — without evidence — will ...

Things are looking a little brighter now. In September, Neuralink received a "breakthrough device" designation from the Food and Drug Administration for its "Blindsight" brain implant, which Elon Musk ...

Oct. 28, 2024 –The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

(RTTNews) - Iterum Therapeutics plc (ITRM) Friday announced that the U.S. Food and Drug Administration (FDA) has approved Iterum's new drug application for Orlynvah (sulopenem etzadroxil and ...

When Max Hodak, CEO of Science and former president of Neuralink, first saw a video of ... Its Blockbuster Drug Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades --Company to Host Conference Call on Monday, October 28 th ...

DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug Administration (FDA) has approved Iterum’s new ...